Hematopoietic activities of interleukin-1 alpha: in vitro and in vivo modulation by an anti-IL-1 receptor antibody

Clicks: 332
ID: 269519
1990
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #1 of 4 articles by views in progress in clinical and biological research

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Hematopoietic activities of interleukin-1 alpha: in vitro and in vivo modulation by an anti-IL-1 receptor antibody
Reference Key
wr1990progresshematopoietic Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Benjamin WR;Chizzonite RA;Tare NS;Plocinski JM;Kaffka KL;McIntyre KW;Faherty DA;Kilian PL;;
Journal progress in clinical and biological research
Year 1990
DOI
DOI not found
URL
https://www.ncbi.nlm.nih.gov/pubmed/2144644
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE Mice animals pubmed abstract nih national institutes of health national library of medicine Antibodies Monoclonal Receptors in vitro techniques inbred c3h pmid:2144644 w r benjamin r a chizzonite p l kilian fluorouracil / pharmacology granulocytes / drug effects granulocytes / physiology hematopoiesis / drug effects hematopoiesis / physiology* interleukin-1 / pharmacology interleukin-1 / physiology* immunologic / immunology immunologic / physiology interleukin-1

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.